<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Turk J Pharm Sci</journal-id><journal-id journal-id-type="iso-abbrev">Turk J Pharm Sci</journal-id><journal-id journal-id-type="pmc-domain-id">3845</journal-id><journal-id journal-id-type="pmc-domain">tjps</journal-id><journal-id journal-id-type="publisher-id">TJPS</journal-id><journal-title-group><journal-title>Turkish Journal of Pharmaceutical Sciences</journal-title></journal-title-group><issn pub-type="ppub">1304-530X</issn><issn pub-type="epub">2148-6247</issn><publisher><publisher-name>Turkish Pharmacists' Association</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7227852</article-id><article-id pub-id-type="pmcid-ver">PMC7227852.1</article-id><article-id pub-id-type="pmcaid">7227852</article-id><article-id pub-id-type="pmcaiid">7227852</article-id><article-id pub-id-type="pmid">32454602</article-id><article-id pub-id-type="doi">10.4274/tjps.87587</article-id><article-id pub-id-type="publisher-id">16065</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Development, Internal and External Validation of Naproxen Sodium Sustained Release Formulation: an Level A <italic toggle="yes">In Vitro-In Vivo</italic> Correlation</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>NARAYANASAMY</surname><given-names initials="R">Ramesh</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref rid="COR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>SHABARAYA</surname><given-names initials="R">Ramakrishna</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1">
<label>1</label>Srinivas College Of Pharmacy, Farengipete Post, Mangalore, Karnataka, India</aff><author-notes><corresp id="COR1">* Address for Correspondence: Phone: 91 824 2232700 E-mail:<email>ramesh7779@gmail.com</email></corresp><fn id="FN1" fn-type="COI-statement"><p>Conflict of Interest: No conflict of interest was declared by the authors.</p></fn></author-notes><pub-date pub-type="ppub"><month>8</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>15</day><month>8</month><year>2017</year></pub-date><volume>14</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">357771</issue-id><fpage>120</fpage><lpage>126</lpage><history><date date-type="received"><day>12</day><month>12</month><year>2016</year></date><date date-type="accepted"><day>26</day><month>1</month><year>2017</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>08</month><year>2017</year></date></event><event event-type="pmc-live"><date><day>22</day><month>05</month><year>2020</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2020-06-11 00:56:16.863"><day>11</day><month>06</month><year>2020</year></date></event></pub-history><permissions><copyright-statement>&#169;Copyright 2017 Turk J Pharm Sci, Published by Galenos Publishing House.</copyright-statement><copyright-year>2017</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="TJPS-14-120.pdf"/><abstract><sec><title>Objectives:</title><p>The aim of the present study was to develop and validate an <italic toggle="yes">in vitro-in vivo</italic> correlation (IVIVC) for naproxen sodium-sustained release tablets and to compare their plasma concentrations over time with the immediate-release tablets.</p></sec><sec><title>Materials and Methods:</title><p><italic toggle="yes">In vitro</italic> release rate data were obtained for each tablet by using the USP Apparatus II, paddle stirrer at 50 rpm in pH 7.4 phosphate buffer. A four-way crossover study was conducted in 6 healthy subjects by administering naproxen sodium sustained release 375 mg and 500 mg of immediate release tablets. Series of blood samples were collected over 24 hours and estimated by using the validated liquid chromatography tandem-mass spectrometry method.</p></sec><sec><title>Results:</title><p>The similarity factor was calculated and it was found that values between, 50 and 100 indicates similarity of the profiles. Assessment of predicted and observed bioavailability was performed and prediction errors (PE) % calculated, as per the Food Drug Administration guidelines, the average absolute PE% of C<sub>max</sub> and AUC of individual formulation was found below 15% for establishment of IVIVC, based on internal prediction strongly suggesting that the naproxen sodium IVIVC models are valid. During external validation the predicted curve for the naproxen sodium sustained-release tablets was found to be identical to immediate release tablets and considered as valid.</p></sec><sec><title>Conclusion:</title><p>IVIVC can serve as a surrogate for <italic toggle="yes">in vivo</italic> bioavailability study and supports biowaivers, supports and validates the dissolution methods and specification settings and assists in quality control during scale-up and post-approval changes. It may be used to predict the variation in site change, process changes and to predict the absorption performance of naproxen sodium products with different release rates.</p></sec></abstract><kwd-group><kwd>IVIVC</kwd><kwd>naproxen sodium</kwd><kwd>sustained release</kwd><kwd>dissolution</kwd><kwd>in vivo bioavailability study</kwd><kwd>internal and external predictability</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>